SYNTHESIS, CONFORMATIONAL CONSIDERATIONS, AND ESTROGEN-RECEPTOR BINDING OF DIASTEREOISOMERS AND ENANTIOMERS OF 1-[4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL]-1,2-DIPHENYLBUTANE (DIHYDROTAMOXIFEN)

被引:21
作者
MCCAGUE, R [1 ]
LECLERCQ, G [1 ]
机构
[1] INST JULES BORDET,SERV MED,CANCEROL MAMMAIRE LAB,B-1000 BRUSSELS,BELGIUM
关键词
D O I
10.1021/jm00393a014
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1761 / 1767
页数:7
相关论文
共 33 条
[1]  
ADAM HK, 1979, BIOCHEM PHARMACOL, V27, P145
[2]   QUANTITATIVE REMOVAL OF A PENTADECAPEPTIDE ACTH FRAGMENT ANALOG FROM A MERRIFIELD RESIN USING AMMONIUM FORMATE CATALYTIC TRANSFER HYDROGENATION - SYNTHESIS OF [ASP25,ALA26,GLY27,GLN30]-ACTH-(25-39)-OH [J].
ANWER, MK ;
SPATOLA, AF ;
BOSSINGER, CD ;
FLANIGAN, E ;
LIU, RC ;
OLSEN, DB ;
STEVENSON, D .
JOURNAL OF ORGANIC CHEMISTRY, 1983, 48 (20) :3503-3507
[3]   ANTIESTROGENIC AND ANTIFERTILITY COMPOUNDS .4. 1,1,2-TRIARYLALKAN-1-OLS AND 1,1,2-TRIARYLALK-1-ENES CONTAINING BASIC ETHER GROUPS [J].
COLLINS, DJ ;
HOBBS, JJ ;
EMMENS, CW .
JOURNAL OF MEDICINAL CHEMISTRY, 1971, 14 (10) :952-&
[4]   DETERMINATION OF TAMOXIFEN AND AN HYDROXYLATED METABOLITE IN PLASMA FROM PATIENTS WITH ADVANCED BREAST-CANCER USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY [J].
DANIEL, CP ;
GASKELL, SJ ;
BISHOP, H ;
NICHOLSON, RI .
JOURNAL OF ENDOCRINOLOGY, 1979, 83 (03) :401-408
[5]   HYDROXY DERIVATIVES OF TAMOXIFEN [J].
FOSTER, AB ;
JARMAN, M ;
LEUNG, OT ;
MCCAGUE, R ;
LECLERCQ, G ;
DEVLEESCHOUWER, N .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (10) :1491-1497
[6]   THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN [J].
FURR, BJA ;
JORDAN, VC .
PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) :127-205
[7]   CONTRASTING ENDOCRINE ACTIVITIES OF CIS AND TRANS ISOMERS IN A SERIES OF SUBSTITUTED TRIPHENYLETHYLENES [J].
HARPER, MJK ;
WALPOLE, AL .
NATURE, 1966, 212 (5057) :87-&
[8]  
JARMAN M, 1986, ANTI-CANCER DRUG DES, V1, P259
[9]   MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTI-ESTROGENIC ACTIVITY [J].
JORDAN, VC ;
COLLINS, MM ;
ROWSBY, L ;
PRESTWICH, G .
JOURNAL OF ENDOCRINOLOGY, 1977, 75 (02) :305-316
[10]  
JORDAN VC, 1984, PHARMACOL REV, V36, P245